Comparing SYMMCORA4 and V-Loc4 Sutures for Vaginal Cuff Closure in Women Having Laparoscopic Total Hysterectomy
Led by Aesculap AG · Updated on 2026-06-02
132
Participants Needed
2
Research Sites
30 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the performance of a new unidirectional barbed suture called SYMMCORA4 in comparison to conventional suture material during vaginal cuff closure in laparoscopic total hysterectomy surgeries in female patients. The study aims to determine if SYMMCORA4 can reduce the time needed for vaginal cuff closure without increasing complication rates. Additionally, the study compares SYMMCORA4 against another barbed suture, V-Loc4, to assess which allows faster closure.
Participants will be randomly assigned to one of two groups one using the SYMMCORA4 suture and the other using the V-Loc4 suture for vaginal cuff closure during their laparoscopic total hysterectomy. Both sutures are approved for use and will be applied according to standard clinical practice and manufacturer instructions. There are no additional invasive procedures or burdens placed on patients beyond routine surgical care.
During the study, researchers will measure the time to close the vaginal cuff during surgery as the primary outcome. They will also track early and longer-term complications, device performance, patient satisfaction, sexual function, pain levels, health status, and length of hospital stay up to six months after surgery. Safety and handling assessments of the sutures will be conducted intraoperatively. Participation lasts from surgery through follow-up visits at discharge, 6-8 weeks, and 6 months postoperatively.
CONDITIONS
Brief Title
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
Research Team
P
Petra Baumann
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Female patients undergoing an elective laparoscopic total hysterectomy
Age 18 years or older
Able to provide written informed consent
You will not qualify if you...
Emergency surgery cases
Open surgery instead of laparoscopic
Immunosuppressive drug treatment within the past 6 months
Allergy or hypersensitivity to suture materials
Participation in another clinical study
Patient non-compliance
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for eligibility assessment
Implementation
Duration - Day of surgery
Participants undergo laparoscopic total hysterectomy with closure of the vaginal cuff using either SYMMCORA® or V-Loc® suture material as part of routine clinical practice.
1 visit (in-person) during surgery
Post-operative Follow-up
Duration - Up to 6 months postoperatively
Participants are monitored for complications, pain levels, sexual function, and overall health status after surgery.
Visits at discharge (up to 10 days after surgery), 6-8 weeks postoperatively, and 6 months postoperatively
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Metabolic Tracing of Tumor and Immune Cells in Ascites from Women with Ovarian Cancer Using Intravenous Labeled Glucose
Phase 01 Study Evaluating Safety and Dose of 177Lu-RAD204, a Radiolabeled Antibody Targeting PD-L1, in Adults With Advanced PD-L1 Positive Solid Tumors
Phase 12a Study of 177Lu-BetaBart, a Radiolabeled Anti-B7-H3 Antibody, for Safety and Early Effectiveness in Adults with Relapsed or Metastatic Solid Tumors
PET Imaging Using 18F-FAPI-74 to Detect Various Cancers Compared to Standard Imaging Methods
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Study of Using 3D-Printed Custom Devices for High-Dose Radiation Treatment in Gynaecological Cancer
Evaluation of 68Ga-SorB PETCT Imaging for Diagnosing Sortilin-Expressing Solid Tumors in Adults with Melanoma, Liver, Lung, Pancreatic, Breast, or Ovarian Cancer
Phase 2 Study of 18F-Fluoroestradiol PETCT Imaging to Assess Estrogen Receptor Activity in Women With Recurrent or Metastatic Uterine Cancer
Phase 12 Study of MDNA11, a Beta-only IL-2 Therapy, Alone or With Pembrolizumab for Advanced Solid Tumors
Study of Preventive Surgery Options for Women with High Genetic Risk of Hereditary Ovarian Cancer
Observing Effects on Cancer Risk, Ovarian Function, and Quality of Life
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Assessment of a novel unidirectional mid-term absorbable barbed suture versus a competitor barbed suture for vaginal cuff closure after gynaecology surgery, study protocol of a randomized controlled trial - BARHYSTER.
Petra Baumann, Lourdes Hinojosa Sánchez, Núria Grané Garcia...